Hepatitis & Sexual Health: Transmission Risks and Prevention Strategies

Viral hepatitis A, B, and C each have distinct sexual transmission profiles. Understanding these differences empowers informed prevention choices.

Transmission Efficiency by Virus and Route

VirusPrimary RouteSexual TransmissionKey Risk Factors
Hepatitis A (HAV)Fecal-oralHigh: Oral-anal contact (rimming), contaminated hands/objectsMSM, travel to endemic areas, drug use
Hepatitis B (HBV)Blood, sexual fluids, perinatalHigh: Vaginal, anal, oral sex; 50–100x more infectious than HIVMultiple partners, STI history, unvaccinated, MSM
Hepatitis C (HCV)BloodLow (heterosexual): ~0–3% per partner/year. Higher: MSM, HIV+, rough sex, menses, genital ulcersBlood exposure during sex; sharing drug equipment

Prevention Strategies

Vaccination (HAV, HBV)

  • HAV: 2-dose series; recommended for MSM, travelers, drug users, chronic liver disease.
  • HBV: 2- or 3-dose series; universal adult vaccination now recommended (ACIP 2022). Post-vaccine titer check for high-risk groups.
  • Twinrix: Combined HAV/HBV vaccine (3 doses).

Barrier Methods

  • Condoms (external/internal) reduce HBV, HCV, and HAV (if oral-anal contact).
  • Dental dams or cut condoms for oral-vaginal/anal sex.
  • Gloves for fisting or manual sex with blood risk.

Behavioral Approaches

  • Reduce partners; mutual monogamy with tested partner.
  • Avoid sex during menses (HCV blood exposure risk).
  • Don't share sex toys without cleaning or condom changes.
  • Never share drug equipment (snorting straws, cookers, syringes).

Biomedical Prevention

  • HCV Treatment = Prevention: Achieving SVR (cure) eliminates transmission risk.
  • HBV Suppression: Antivirals (tenofovir/entecavir) lower viral load, reducing transmission.
  • PrEP (Tenofovir/Emtricitabine): Prevents HIV and HBV (not HAV or HCV).

Special Populations

  • MSM: Highest sexual HCV risk (chemsex, group sex, fisting). Vaccinate for HAV/HBV; test HCV every 6–12 months; consider PrEP.
  • HIV Coinfection: Increases sexual HCV transmission and HBV reactivation risk. Integrated care is essential.
  • Pregnancy: HBV: Antivirals in 3rd trimester + HBIG/vaccine to infant prevents 95% of transmission. HCV: No prophylaxis; treat postpartum.

Testing Recommendations

  • All adults: HCV once; HBV if risk factors; HAV if risk factors.
  • Pregnancy: HBsAg, HCV, HIV each pregnancy.
  • Post-exposure: HBV PEP (HBIG + vaccine) within 24 hours; HCV early RNA monitoring.

Sexual health is whole health. Vaccinate, test, treat, communicate.

Neuro-Linguistic Programming (NLP) - Related Articles